VTP 950
Alternative Names: COVID-2019 vaccine; COVID-2019 vaccine - University of Oxford/Barinthus Biotherapeutics; VTP-950Latest Information Update: 28 Sep 2024
Price :
$50 *
At a glance
- Originator University of Oxford
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Sep 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in United Kingdom (Parenteral)
- 31 Aug 2020 Vaccitech in-licenses technology patents from University of Oxford (Vaccitech website, August 2020)
- 27 Aug 2020 Vaccitech plans a phase I trial for COVID-2019 infections (Prevention) (Parenteral) in 2021